Arno Andrew - Insider Non-Derivative Transactions at Oncocyte Corp (OCX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 26, 2024, Arno Andrew's relationship to Oncocyte Corp (OCX) is Director, and currently has 81,554 shares of Common Stock, no par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OCX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Arno Andrew - Insider Non-Derivative Transactions of OCX Common Stock, no par value

Arno Andrew - Insider Non-Derivative Transactions at OCX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 27, 2024	P -- (Common Stock, no par value)	12500	2.11	81554
Apr 12, 2024	P -- (Common Stock, no par value)	33898	2.95	69054
Jun 24, 2023	Acquisition -- (Common Stock, no par value)	30000	0	703133
Apr 4, 2023	Acquisition -- (Common Stock, no par value)	141084	0.35	156084
Apr 4, 2023	Acquisition -- (Common Stock, no par value)	141084	0.35	673133